Martin C Michel Selected Research

Terazosin (Hytrin)

9/2014	Cardiovascular and ocular safety of α1-adrenoceptor antagonists in the treatment of male lower urinary tract symptoms.
2/2006	In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits.
1/2006	Effects of alpha(1)-adrenoceptor antagonists on male sexual function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin C Michel Research Topics

Disease

35	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 01/2002
15	Hypertension (High Blood Pressure) 05/2016 - 07/2003
13	Lower Urinary Tract Symptoms 07/2021 - 01/2004
11	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2021 - 01/2004
8	Nocturia 01/2020 - 09/2005
5	Neoplasms (Cancer) 01/2022 - 10/2008
5	Constipation 06/2020 - 11/2005
5	Heart Failure 01/2020 - 12/2010
5	Hypertrophy 11/2018 - 04/2007
4	Major Depressive Disorder (Major Depressive Disorders) 04/2012 - 01/2006
4	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 09/2011 - 03/2008
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 08/2015
3	Dementia (Dementias) 01/2022 - 10/2018
3	Obesity 01/2019 - 10/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 12/2008
3	Pain (Aches) 02/2017 - 09/2011
3	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 08/2008
3	Erectile Dysfunction 07/2013 - 07/2002
3	Stress Urinary Incontinence 04/2013 - 11/2005
2	Inflammation (Inflammations) 01/2022 - 09/2011
2	Disease Progression 07/2021 - 01/2021
2	Urinary Retention 07/2021 - 04/2011
2	Diarrhea 01/2020 - 01/2012
2	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2018 - 09/2011
2	Cough 01/2018 - 02/2017
2	Fatigue 02/2017 - 11/2005
2	Type 2 Diabetes Mellitus (MODY) 03/2016 - 05/2008
2	Hypotension (Low Blood Pressure) 09/2014 - 10/2008
2	Myocardial Infarction 01/2014 - 10/2008
2	Polyuria 07/2013 - 03/2009
2	Urinary Incontinence 02/2013 - 01/2008
2	Urologic Diseases (Urinary Tract Disease) 01/2006 - 01/2004
2	Urge Urinary Incontinence (Urge Incontinence) 08/2004 - 09/2002
1	Rare Diseases (Rare Disease) 01/2022
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2020
1	Atrial Fibrillation 03/2018
1	Chest Pain (Chest Pains) 01/2018
1	Bronchitis 01/2018

Drug/Important Bio-Agent (IBA)

17	Pharmaceutical PreparationsIBA 01/2022 - 02/2006
13	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 10/2019 - 09/2002
13	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019 - 07/2002
10	Tamsulosin (Flomax)FDA LinkGeneric 07/2021 - 01/2004
8	Muscarinic AntagonistsIBA 01/2022 - 08/2004
6	mirabegronIBA 01/2018 - 03/2013
6	fesoterodine FDA Link 01/2014 - 07/2008
5	Antihypertensive Agents (Antihypertensives)IBA 09/2014 - 01/2004
5	Tolterodine Tartrate (Detrol)FDA Link 01/2009 - 09/2002
4	propiverineIBA 01/2021 - 11/2006
4	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2018 - 03/2009
4	Doxazosin (Cardura)FDA LinkGeneric 09/2014 - 01/2006
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 01/2018
3	Nerve Growth Factor (NGF)IBA 01/2022 - 09/2011
3	solabegronIBA 05/2016 - 11/2012
3	Terazosin (Hytrin)FDA LinkGeneric 09/2014 - 01/2006
3	oxybutynin (Tavor)FDA LinkGeneric 01/2009 - 01/2002
2	Insulin (Novolin)FDA Link 01/2022 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 11/2018 - 01/2018
2	Cholinergic Agents (Cholinergics)IBA 03/2018 - 03/2008
2	Angiotensin II Type 1 Receptor BlockersIBA 01/2016 - 04/2013
2	Biological ProductsIBA 01/2014 - 06/2004
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 04/2013 - 11/2005
2	Proteins (Proteins, Gene)FDA Link 12/2010 - 04/2007
2	GTP-Binding Proteins (G-Protein)IBA 12/2010 - 01/2009
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 03/2009 - 01/2009
2	Paroxetine (Paxil)FDA LinkGeneric 03/2009 - 01/2009
2	darifenacin FDA Link 01/2009 - 11/2006
2	Solifenacin Succinate FDA Link 01/2009 - 11/2006
2	rho-Associated KinasesIBA 06/2008 - 06/2005
2	alfuzosin (UroXatral)FDA Link 02/2006 - 01/2006
1	Soluble Guanylyl CyclaseIBA 01/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022
1	Inositol (Myoinositol)IBA 01/2022
1	Serotonin ReceptorsIBA 01/2022
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2022
1	daidzeinIBA 01/2022
1	Dutasteride (Avodart)FDA Link 07/2021
1	Lactulose (Duphalac)FDA LinkGeneric 06/2020
1	Bisacodyl (Bicol)FDA Link 06/2020
1	picosulfate sodiumIBA 06/2020
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 06/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	DiureticsIBA 01/2020
1	Hypnotics and Sedatives (Sedatives)IBA 01/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2018
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2018
1	AntioxidantsIBA 01/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018
1	Local AnestheticsIBA 01/2018
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2018
1	Ambroxol (Mucosolvan)IBA 01/2018
1	Finasteride (Propecia)FDA LinkGeneric 01/2018
1	abobotulinumtoxinA FDA Link 01/2018
1	SecretagoguesIBA 01/2018
1	onabotulinum toxin AIBA 01/2018
1	TabletsIBA 01/2018
1	Phosphodiesterase InhibitorsIBA 01/2018

Therapy/Procedure

6	Therapeutics 07/2021 - 04/2011
3	Injections 01/2018 - 02/2006
1	Enema (Enemas) 06/2020
1	Duration of Therapy 01/2018